KPIs & Operating Metrics(New)
Balance Sheet
AssetsCommon EquityCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barclays (BCS) Cash & Equivalents (2018 - 2022)

Barclays has reported Cash & Equivalents over the past 4 years, most recently at $349.4 billion for Q4 2021.

  • For Q4 2021, Cash & Equivalents rose 25.92% year-over-year to $349.4 billion; the TTM value through Dec 2021 reached $349.4 billion, up 25.92%, while the annual FY2021 figure was $356.6 billion, 32.16% up from the prior year.
  • Cash & Equivalents for Q4 2021 was $349.4 billion at Barclays, up from $277.5 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $349.4 billion in Q4 2021 and troughed at $214.2 billion in Q4 2019.
  • A 4-year average of $272.6 billion and a median of $263.4 billion in 2018 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: fell 14.07% in 2019 and later grew 29.53% in 2020.
  • Year by year, Cash & Equivalents stood at $249.3 billion in 2018, then fell by 14.07% to $214.2 billion in 2019, then grew by 29.53% to $277.5 billion in 2020, then increased by 25.92% to $349.4 billion in 2021.
  • Business Quant data shows Cash & Equivalents for BCS at $349.4 billion in Q4 2021, $277.5 billion in Q4 2020, and $214.2 billion in Q4 2019.